TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CEFUROXIME AXETIL

CEFUROXIME AXETIL
Infectious Disease Approved 2002-02-15
11
Indications
--
Phase 3 Trials
24
Years on Market

Details

Status
Prescription
First Approved
2002-02-15
Routes
ORAL
Dosage Forms
TABLET, FOR SUSPENSION

CEFUROXIME AXETIL Approval History

Loading approval history...

What CEFUROXIME AXETIL Treats

9 indications

CEFUROXIME AXETIL is approved for 9 conditions since its original approval in 2002. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pharyngitis
  • Tonsillitis
  • Acute Otitis Media
  • Maxillary Sinusitis
  • Skin Infection
  • Urinary Tract Infection
  • Gonorrhea
  • Lyme Disease
Source: FDA Label

Drugs Similar to CEFUROXIME AXETIL

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

SUPRAX
CEFIXIME
4 shared
Lupin
Shared indications:
Urinary Tract InfectionPharyngitisTonsillitis +1 more
AZITHROMYCIN
AZITHROMYCIN
3 shared
Aurobindo Pharma
Shared indications:
Acute Otitis MediaPharyngitisTonsillitis
CEFPODOXIME PROXETIL
CEFPODOXIME PROXETIL
3 shared
ANDA REPOSITORY
Shared indications:
Acute Otitis MediaPharyngitisTonsillitis
CLARITHROMYCIN
CLARITHROMYCIN
3 shared
Teva
Shared indications:
PharyngitisTonsillitisAcute Otitis Media
BACTRIM
SULFAMETHOXAZOLE
2 shared
Sun Pharma
Shared indications:
Urinary Tract InfectionAcute Otitis Media
BACTRIM DS
SULFAMETHOXAZOLE
2 shared
Sun Pharma
Shared indications:
Urinary Tract InfectionAcute Otitis Media
CEFUROXIME
CEFUROXIME
2 shared
Hikma
Shared indications:
Urinary Tract InfectionGonorrhea
SULFATRIM PEDIATRIC
SULFAMETHOXAZOLE
2 shared
PHARM ASSOC
Shared indications:
Urinary Tract InfectionAcute Otitis Media
TRIMETHOPRIM
TRIMETHOPRIM
2 shared
Dr. Reddy's
Shared indications:
Urinary Tract InfectionAcute Otitis Media
AMOXICILLIN PEDIATRIC
AMOXICILLIN
1 shared
Teva
Shared indications:
Urinary Tract Infection
AMPICILLIN SODIUM
AMPICILLIN SODIUM
1 shared
SAGENT PHARMS INC
Shared indications:
Urinary Tract Infection
ANCOBON
FLUCYTOSINE
1 shared
BAUSCH
Shared indications:
Urinary Tract Infection
ARIKAYCE KIT
AMIKACIN SULFATE
1 shared
INSMED INC
Shared indications:
Urinary Tract Infection
AUGMENTIN '125'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN '250'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN '875'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN ES-600
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Acute Otitis Media
AUGMENTIN XR
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AZACTAM
AZTREONAM
1 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract Infection
AZTREONAM
AZTREONAM
1 shared
Pfizer
Shared indications:
Urinary Tract Infection
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFUROXIME AXETIL FDA Label Details

Pro

Indications & Usage

Cefuroxime axetil tablet is a cephalosporin antibacterial drug indicated for the treatment of the following infections due to susceptible bacteria: Pharyngitis/tonsillitis (adults and pediatric patients) Acute bacterial otitis media (pediatric patients) Acute bacterial maxillary sinusitis (adults and pediatric patients) Acute bacterial exacerbations of chronic bronchitis (adults and pediatric patients 13 years and older) Uncomplicated skin and skin-structure infections (adults and pediatric patients 13 years and older) Uncomplicated urinary tract infections (adults and pediatric patients 13 ye...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.